Abstract
Neuromyelitis optica (NMO) is an autoimmune inflammatory disorder of the CNS with a predilection for the optic nerves and spinal cord, often with longitudinally extensive transverse myelitis (LETM) on MRI. The discovery of aquaporin-4 (AQP4)-immunoglobulin G (IgG), an antibody against the astrocyte water channel in the CNS, clearly identified NMO as a disease separate from MS. The high specificity of AQP4-IgG has permitted recognition of a wider spectrum of clinical and radiologic features related to NMO. Other sites of CNS involvement not restricted to the optic nerves or spinal cord have been described in AQP4-IgG-seropositive patients such as the diencephalon, brainstem, and brain hemispheric white matter. In anti-AQP4-IgG-seropositive patients, partial clinical (e.g., only myelitis) and MRI findings have been recognized, while conversely, NMO-like MRI findings and clinical features can occur in anti-AQP4-IgG-seronegative patients, sometimes with anti-MOG antibodies.
The term NMO spectrum disorder (NMOSD) has been adopted to reflect the clinical, serological, and radiological diversity. Clinical features alone may be insufficient to diagnose NMOSD; cerebrospinal fluid (CSF) analysis and radiological techniques, in particular MRI, are required to exclude other disorders and reveal the characteristic optic nerve, spinal cord, and cerebral findings. The value of MRI in the diagnostic process is particularly relevant in patients who are anti-AQP4-IgG negative or when serologic testing is unavailable. This chapter gives special consideration to the value of clinical neuroradiology in the diagnosis of NMOSD and in the distinction from MS (with short segment lesions rather than LETM) and other immune-mediated inflammatory demyelinating diseases.
This publication is endorsed by: European Society of Neuroradiology (www.esnr.org).
Similar content being viewed by others
Abbreviations
- ADEM:
-
Acute disseminated encephalomyelitis
- AQP4:
-
Aquaporin-4 channel
- CNS:
-
Central nervous system
- Fat-sat:
-
Fat saturation
- Gad:
-
Gadolinium
- GFAP:
-
Glial fibrillary acidic protein
- IgG:
-
Immunoglobulin-G
- IVMP:
-
High-dose intravenous steroids
- LEON:
-
Longitudinally extensive optic neuritis
- LETM:
-
Longitudinally extensive transverse myelitis
- MOG:
-
Myelin oligodendrocyte glycoprotein
- MRI:
-
Magnetic resonance imaging
- MS:
-
Multiple sclerosis
- NMOSD:
-
Neuromyelitis spectrum disorder
- ON:
-
Optic neuritis
- STIR:
-
Short tau inversion recovery
- T2w:
-
T2-weighted
References
Ciccarelli O, Cohen JA, Reingold SC, Weinshenker BG. Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders. International Conference on Spinal Cord Involvement and Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders. Lancet Neurol. 2019;18(2):185–197. https://doi.org/10.1016/S1474-4422(18)30460-5.
Flanagan EP, Weinshenker BG, Krecke KN, Lennon VA, Lucchinetti CF, McKeon A, Wingerchuk DM, Shuster EA, Jiao Y, Horta ES, Pittock SJ. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders. JAMA Neurol. 2015;72(1):81–7. https://doi.org/10.1001/jamaneurol.2014.2137.
Geraldes R, Ciccarelli O, Barkhof F, De Stefano N, Enzinger C, Filippi M, et al. The current role of MRI in differentiating multiple sclerosis from its imaging mimics. Nat Rev Neurol. 2018;14:199.
Hacohen Y, Mankad K, Chong W, Barkhof F, Vincent A, Lim M, et al. Diagnostic algorithm for relapsing acquired demyelinating syndromes in children. Neurology. 2017;89:269–78.
Jurynczyk M, Geraldes R, Probert F, Woodhall MR, Waters P, Tackley G, et al. Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis. Brain. 2017;140:617–27.
Kim W, Kim S-H, Hyun Lee S, Feng Li X, Jin Kim H. Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorder. Mult Scler J. 2011;17(9):1107–12. https://doi.org/10.1177/1352458511404917.
Kim W, Kim SH, Huh SY, Kim HJ. Brain abnormalities in neuromyelitis optica spectrum disorder. Mult Scler Int. 2012;2012:735486.
Kim HJ, Paul F, Lana-Peixoto MA, Tenembaum S, Asgari N, Palace J, et al. MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology. 2015;84:1165–73.
Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66(10):1485–9.
Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85:177–89.
Yonezu T, Ito S, Mori M, Ogawa Y, Makino T, Uzawa A, et al. “Bright spotty lesions” on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis. Mult Scler. 2014;20:331–7.
Zabad R, Stewart R, Healey KM. Pattern recognition of the multiple sclerosis syndrome. Brain Sci. 2017;7(10):138. https://doi.org/10.3390/brainsci7100138.
Suggested Readings
Dubey D, Pittock SJ, Krecke KN, Morris PP, Sechi E, Zalewski NL, et al. Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody. JAMA Neurol 2018. https://doi.org/10.1001/jamaneurol.2018.4053. [Epub ahead of print].
Dutra BG, da Rocha AJ, Nunes RH, Júnior MACM. Neuromyelitis optica spectrum disorders: spectrum of MR imaging findings and their differential diagnosis. Radiographics. 2018;38:169–19.
Huh S-Y, Min J-H, Kim W, Kim S-H, Kim HJ, Kim B-J, et al. The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders. Mult Scler J. 2014;20:695–704.
Matthews L, Marasco R, Jenkinson M, Küker W, Luppe S, Leite MI, et al. Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution. Neurology. 2013;80:1330–7.
Pandit L, Asgari N, Apiwattanakul M, Palace J, Paul F, Leite M, et al. Demographic and clinical features of neuromyelitis optica: a review. Mult Scler J. 2015;21:845–53.
Weinshenker BG, Wingerchuk DM, editors. Neuromyelitis spectrum disorders. Mayo Clin Proc. 2017;92:663–679.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
Wuerfel, J., Rovira, A., Paul, F., Barkhof, F. (2019). Neuromyelitis Optica Spectrum Disorders (NMOSD). In: Barkhof, F., Jager, R., Thurnher, M., Rovira Cañellas, A. (eds) Clinical Neuroradiology. Springer, Cham. https://doi.org/10.1007/978-3-319-61423-6_71-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-61423-6_71-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-61423-6
Online ISBN: 978-3-319-61423-6
eBook Packages: Springer Reference MedicineReference Module Medicine